Significant inverse association of equol-producer status with coronary artery calcification but not dietary isoflavones in healthy Japanese men

British Journal of Nutrition

Volumn 117, Issue 2, 2017, Pages 260-266

  Ahuja, Vasudha ^a   Miura, Katsuyuki ^b   Vishnu, Abhishek ^a   Fujiyoshi, Akira ^b   Evans, Rhobert ^a   Zaid, Maryam ^b   Miyagawa, Naoko ^b   Hisamatsu, Takashi ^b,c   Kadota, Aya ^b   Okamura, Tomonori ^d   Ueshima, Hirotsugu ^b   Sekikawa, Akira ^a  

^a UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^b SHIGA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

^c SHIMANE UNIVERSITY   (Japan)

^d KEIO UNIVERSITY   (Japan)

Author keywords

Coronary artery calcification; Equol producers; Isoflavones; Japanese; Men

Indexed keywords

DAIDZEIN; EQUOL; GENISTEIN; BIOLOGICAL MARKER; ISOFLAVONE DERIVATIVE;

ADULT; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; CORONARY ARTERY CALCIFICATION; CROSS-SECTIONAL STUDY; DIETARY INTAKE; HUMAN; INFORMED CONSENT; JAPANESE (PEOPLE); LIFESTYLE; MALE; POPULATION RESEARCH; PREVALENCE; PROSPECTIVE STUDY; ATHEROSCLEROSIS; BACTERIUM; BLOOD; CALCINOSIS; CORONARY BLOOD VESSEL; DIET; DRUG EFFECTS; JAPAN; METABOLISM; MIDDLE AGED; ODDS RATIO; PATHOLOGY; PHENOTYPE; STATISTICAL MODEL;

ADULT; ATHEROSCLEROSIS; BACTERIA; BIOMARKERS; CALCINOSIS; CORONARY VESSELS; CROSS-SECTIONAL STUDIES; DIET; EQUOL; HUMANS; ISOFLAVONES; JAPAN; LOGISTIC MODELS; MALE; MIDDLE AGED; ODDS RATIO; PHENOTYPE;

EID: 85013237620     PISSN: 00071145     EISSN: 14752662     Source Type: Journal    
DOI: 10.1017/S000711451600458X     Document Type: Article

References (48)

1. Setchell KD (1998) Phytoestrogens: the biochemistry, physiology, and implications for human health of soy isoflavones. Am J Clin Nutr 68, 6 Suppl., 1333S-1346S.S.
2. Clarkson TB & Anthony MS (1998) Phytoestrogens and coronary heart disease. Baillieres Clin Endocrinol Metab 12, 589-604.
3. Taku K, Umegaki K, Sato Y, et al. (2007) Soy isoflavones lower serum total and LDL cholesterol in humans: a meta-analysis of 11 randomized controlled trials. Am J Clin Nutr 85, 1148-1156.
4. Taku K, Lin N, Cai D, et al. (2010) Effects of soy isoflavone extract supplements on blood pressure in adult humans: systematic review and meta-analysis of randomized placebocontrolled trials. J Hypertens 28, 1971-1982.
5. Teragawa H, Higashi Y & Kihara Y (2008) Effect of isoflavone supplement on endothelial function: does efficacy vary with atherosclerotic burden? Eur Heart J 29, 2710-2712.
6. Walker HA, Dean TS, Sanders TA, et al. (2001) The phytoestrogen genistein produces acute nitric oxide-dependent dilation of human forearm vasculature with similar potency to 17beta-estradiol. Circulation 103, 258-262.
7. Wiseman H, O'Reilly JD, Adlercreutz H, et al. (2000) Isoflavone phytoestrogens consumed in soy decrease F(2)-isoprostane concentrations and increase resistance of lowdensity lipoprotein to oxidation in humans. Am J Clin Nutr 72, 395-400.
8. Jenkins DJ, Kendall CW, Vidgen E, et al. (2000) Effect of soy-based breakfast cereal on blood lipids and oxidized low-density lipoprotein. Metabolism 49, 1496-1500.
9. Nestel PJ, Yamashita T, Sasahara T, et al. (1997) Soy isoflavones improve systemic arterial compliance but not plasma lipids in menopausal and perimenopausal women. Arterioscler Thromb Vasc Biol 17, 3392-3398.
10. Kim H, Peterson TG & Barnes S (1998) Mechanisms of action of the soy isoflavone genistein: emerging role for its effects via transforming growth factor beta signaling pathways. Am J Clin Nutr 68, 6 Suppl., 1418S-1425S.S.
11. Wilcox JN & Blumenthal BF (1995) Thrombotic mechanisms in atherosclerosis: potential impact of soy proteins. J Nutr 125, 3 Suppl., 631S-638S.S.
12. Anthony MS, Clarkson TB, Bullock BC, et al. (1997) Soy protein versus soy phytoestrogens in the prevention of diet-induced coronary artery atherosclerosis of male cynomolgus monkeys. Arterioscler Thromb Vasc Biol 17, 2524-2531.
13. Wagner JD, Cefalu WT, Anthony MS, et al. (1997) Dietary soy protein and estrogen replacement therapy improve cardiovascular risk factors and decrease aortic cholesteryl ester content in ovariectomized cynomolgus monkeys. Metabolism 46, 698-705.
14. Zhang X, Shu XO, Gao Y-T, et al. (2003) Soy food consumption is associated with lower risk of coronary heart disease in Chinese women. J Nutr 133, 2874-2878.
15. Kokubo Y, Iso H, Ishihara J, et al. (2007) Association of dietary intake of soy, beans, and isoflavones with risk of cerebral and myocardial infarctions in Japanese populations: the Japan Public Health Center-based (JPHC) study cohort I. Circulation 116, 2553-2562.
16. Zhang X, Gao YT, Yang G, et al. (2012) Urinary isoflavonoids and risk of coronary heart disease. Int J Epidemiol 41, 1367-1375.
17. Hodis HN, Mack WJ, Kono N, et al. (2011) Isoflavone soy protein supplementation and atherosclerosis progression in healthy postmenopausal women a randomized controlled trial. Stroke 42, 3168-3175.
18. Setchell KD & Clerici C (2010) Equol: history, chemistry, and formation. J Nutr 140, 1355S-1362S.S.
19. Setchell KD & Clerici C (2010) Equol: pharmacokinetics and biological actions. J Nutr 140, 1363S-1368S.S.
20. Rafii F, Sutherland JB, Bridges BM, et al. (2012) Relationship of dietary soy protein to daidzein metabolism by cultures of intestinal microflora from monkeys. Food Nutr Sci 3, 7.
21. Setchell KD & Cole SJ (2006) Method of defining equolproducer status and its frequency among vegetarians. J Nutr 136, 2188-2193.
22. Greenland P, Bonow RO, Brundage BH, et al. (2007) ACCF/ AHA 2007 clinical expert consensus document on coronary artery calcium scoring by computed tomography in global cardiovascular risk assessment and in evaluation of patients with chest pain: a report of the American College of Cardiology Foundation Clinical Expert Consensus Task Force (ACCF/ AHA Writing Committee to Update the 2000 Expert Consensus Document on Electron Beam Computed Tomography). Circulation 115, 402-426.
23. Sekikawa A, Curb JD, Ueshima H, et al. (2008) Marine-derived n-3 fatty acids and atherosclerosis in Japanese, Japanese-American, and white men: a cross-sectional study. J Am Coll Cardiol 52, 417-424.
24. Okamura T, Kadowaki T, Sekikawa A, et al. (2006) Alcohol consumption and coronary artery calcium in middle-aged Japanese men. Am J Cardiol 98, 141-144.
25. Weber MA, Schiffrin EL, White WB, et al. (2014) Clinical practice guidelines for the management of hypertension in the community a statement by the American Society of Hypertension and the International Society of Hypertension. J Hypertens 32, 3-15.
26. American Diabetes Association (2014) Diagnosis and classification of diabetes mellitus. Diabetes Care 37, Suppl. 1, S81-S90.
27. Pumford SL, Morton MM, Turkes A, et al. (2002) Determination of the isoflavonoids genistein and daidzein in biological samples by gas chromatography-mass spectrometry. Ann Clin Biochem 39, 281-292.
28. Agatston AS, Janowitz WR, Hildner FJ, et al. (1990) Quantification of coronary artery calcium using ultrafast computed tomography. J Am Coll Cardiol 15, 827-832.
29. Sekikawa A, Miura K, Lee S, et al. (2014) Long chain n-3 polyunsaturated fatty acids and incidence rate of coronary artery calcification in Japanese men in Japan and white men in the USA: population based prospective cohort study. Heart 100, 569-573.
30. Setchell KD, Brown NM & Lydeking-Olsen E (2002) The clinical importance of the metabolite equol-a clue to the effectiveness of soy and its isoflavones. J Nutr 132, 3577-3584.
31. Morton MS, Arisaka O, Miyake N, et al. (2002) Phytoestrogen concentrations in serum from Japanese men and women over forty years of age. J Nutr 132, 3168-3171.
32. Curtis PJ, Potter J, Kroon PA, et al. (2013) Vascular function and atherosclerosis progression after 1 y of flavonoid intake in statin-treated postmenopausal women with type 2 diabetes: a double-blind randomized controlled trial. Am J Clin Nutr 97, 936-942.
33. Liu ZM, Ho SC, Chen YM, et al. (2014) Whole soy, but not purified daidzein, had a favorable effect on improvement of cardiovascular risks: a 6-month randomized, doubleblind, and placebo-controlled trial in equol-producing postmenopausal women. Mol Nutr Food Res 58, 709-717.
34. van der Schouw YT, Kreijkamp-Kaspers S, Peeters PH, et al. (2005) Prospective study on usual dietary phytoestrogen intake and cardiovascular disease risk in Western women. Circulation 111, 465-471.
35. Klein MA, Nahin RL, Messina MJ, et al. (2010) Guidance from an NIH workshop on designing, implementing, and reporting clinical studies of soy interventions. J Nutr 140, 1192S-1204S.S.
36. Adlercreutz H, Markkanen H & Watanabe S (1993) Plasma concentrations of phyto-oestrogens in Japanese men. Lancet 342, 1209-1210.
37. Heald CL, Bolton-Smith C, Ritchie MR, et al. (2006) Phytooestrogen intake in Scottish men: use of serum to validate a self-administered food-frequency questionnaire in older men. Eur J Clin Nutr 60, 129-135.
38. Messina M (2004) Western soy intake is too low to produce health effects. Am J Clin Nutr 80, 528-529; author reply 9-30.
39. Messina M (2010) Insights gained from 20 years of soy research. J Nutr 140, 2289S-2295S.S.
40. Messina M, Nagata C & Wu AH (2006) Estimated Asian adult soy protein and isoflavone intakes. Nutr Cancer 55, 1-12.
41. Fraser GE, Franke AA, Jaceldo-Siegl K, et al. (2010) Reliability of serum and urinary isoflavone estimates. Biomarkers 15, 135-139.
42. Ministry of Health and Welfare (2000) National Nutrition Survey 1998. Tokyo: Daiichi Shuppan Publisher.
43. Yamamoto S, Sobue T, Sasaki S, et al. (2001) Validity and reproducibility of a self-administered food-frequency questionnaire to assess isoflavone intake in a Japanese population in comparison with dietary records and blood and urine isoflavones. J Nutr 131, 2741-2747.
44. Jenab M, Slimani N, Bictash M, et al. (2009) Biomarkers in nutritional epidemiology: applications, needs and new horizons. Hum Genet 125, 507-525.
45. Iwasaki M, Inoue M, Otani T, et al. (2008) Plasma isoflavone level and subsequent risk of breast cancer among Japanese women: a nested case-control study from the Japan Public Health Center-based prospective study group. J Clin Oncol 26, 1677-1683.
46. Lampe JW (2009) Is equol the key to the efficacy of soy foods? Am J Clin Nutr 89, 1664S-1667S.
47. Blaha M, Budoff MJ, Shaw LJ, et al. (2009) Absence of coronary artery calcification and all-cause mortality. JACC Cardiovasc Imaging 2, 692-700.
48. Uchiyama SUT, Kumemura M, Imaizumi K, et al. (2004) Streptococcus and isofiavone-containing composition. Otsuka Pharmaceutical Co. Ltd (inventor), assignee.